In hAPP (J20) mice and LDLR−/− mice, which respectively mimic AD and vascular dementia, inhibiting mTOR by rapamycin ameliorates BBB breakdown manifested as upregulated TJ proteins and attenuated vascular inflammation (Van [220]). Here, MTOR is linked to Alzheimer disease.